ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,304,673 | -19.8% | 220,384 | +0.5% | 0.00% | – |
| Q2 2023 | $1,627,473 | +286.5% | 219,336 | +392.2% | 0.00% | – |
| Q1 2023 | $421,092 | -11.7% | 44,560 | -0.5% | 0.00% | – |
| Q4 2022 | $476,949 | +65.0% | 44,784 | +14.1% | 0.00% | – |
| Q3 2022 | $289,000 | +57.9% | 39,233 | +3.1% | 0.00% | – |
| Q2 2022 | $183,000 | -4.2% | 38,054 | +1.8% | 0.00% | – |
| Q1 2022 | $191,000 | -16.6% | 37,370 | -1.6% | 0.00% | – |
| Q4 2021 | $229,000 | -32.4% | 37,986 | -0.9% | 0.00% | – |
| Q3 2021 | $339,000 | +12.6% | 38,329 | +0.7% | 0.00% | – |
| Q2 2021 | $301,000 | +45.4% | 38,052 | +40.4% | 0.00% | – |
| Q1 2021 | $207,000 | -2.8% | 27,102 | -0.8% | 0.00% | – |
| Q4 2020 | $213,000 | -18.4% | 27,320 | +1.4% | 0.00% | – |
| Q3 2020 | $261,000 | – | 26,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
| Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
| Sentinus, LLC | 22,500 | $166,000 | 0.10% |
| Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
| J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
| EMFO, LLC | 1,666 | $12,000 | 0.01% |
| Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
| Jump Financial, LLC | 23,400 | $173,000 | 0.01% |